Navigation Links
BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label

FLORHAM PARK, N.J., Dec. 17 /PRNewswire/ -- BASF today announced that the Environmental Protection Agency (EPA) has approved the use of Aseptrol® S10 - Tab in H1N1 sanitization operations in institutional and industrial facilities, such as, schools, hospitals, government buildings, retail and restaurants, and recreational facilities. Aseptrol S10 - Tab is based on Chlorine dioxide (CIO2) release technology.

"Aseptrol S10 - Tab delivers a broad spectrum disinfectant as stated in the EPA label and kills a large number of pathogens, such as H1N1 virus, Avian Influenza A (H3N2), Influenza A, and HIV, on contact surfaces," said Gary Dee, Business Director, Home and Personal Care, Care Chemicals North America at BASF. "The tablet is stable when dry and is packed in foil pouches, saving energy and reducing overall logistics costs."

High efficiency CIO2 is formed in the pores of the tablet when immersed in water. As the tablet dissolves, this powerful oxidizer disperses into the bulk solution. Using the Aseptrol S10 - Tab is as easy as Drop, Spray and Wipe: Drop the tablet in a spray bottle containing water, spray it evenly on a non-porous surface and wipe the surface until dry. Treated surfaces must remain wet for 10 minutes (or 30 minutes for Foot and Mouth Disease Virus). The solution does not leave a residue.

Care Chemicals and Formulators

BASF's Care Chemicals division develops, produces and markets a comprehensive range of products for nutrition, pharmaceuticals, cosmetics, detergents & cleaners, and industrial & chemical applications. As a result of focused research and development, we are a preferred partner of our customers worldwide.

The products offered by BASF Care Chemicals include vitamins, carotenoids, organic acids, active pharmaceutical ingredients and excipients, aroma chemicals and cosmetic ingredients, chelating agents, surfactants, biocides, waxes and wax emulsions as well as metal surface treatment products.

BASF - The Chemical Company. We don't make a lot of the products you buy. We make a lot of the products you buy better.®

BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 15,000 employees in North America, and had sales of approximately $17.5 billion in 2008. For more information about BASF's North American operations, or to sign up to receive news releases by e-mail, visit

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics and performance products to agricultural products, fine chemicals and oil and gas. As a reliable partner, BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of more than euro 62 billion in 2008 and had approximately 97,000 employees as of the end of the year. Further information on BASF is available on the Internet at

Aseptrol S10 - Tab is a registered trademark of BASF Corporation.

SOURCE BASF Corporation

SOURCE BASF Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CareCentrix Receives URAC Health Utilization Management Accreditation
2. Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
3. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
4. Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets
5. EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution
6. Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
7. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
8. Greenway Medical Technologies PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification
9. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
10. Mylan Receives Approval for Generic Version of Antiepileptic Keppra(R) 1000 mg
11. Dynatronics Receives 180-Day NASDAQ Extension
Post Your Comments:
(Date:12/1/2015)... , BANGALORE, India and ... N.V. (NASDAQ, TASE: MYL) today announced that it expects ... and for developing country markets funded by international donors, ... mg + Efavirenz 400 mg) for $99 per patient, ... Initiative (CHAI) to develop TLE400. The significantly reduced price ...
(Date:12/1/2015)... CARLSBAD, Calif. , Dec. 1, 2015 ... medicine products and services, announced today that it has ... care services organization. Members served by Novation will have ... therapy devices, sports bracing products and soft goods dedicated ... --> The aging U.S. population, rising ...
(Date:12/1/2015)... 2015 Building on its 25-year legacy ... (NYSE: JNJ ) today announced four new ... significantly reduce the burden of HIV incidence, especially ... of new HIV infections among adolescents in sub-Saharan ... these new initiatives include collaborations with the U.S. ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 02, 2015 , ... ... events and association with initiation of treatment for osteoporosis ”. , As corresponding ... pharmacological treatment in patients diagnosed with osteoporosis. Based on a large US managed ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an article published ... discrimination claim against the U.S. Department of Health and Human Services, claiming that any ... plans are breaking the clause in the law prohibiting the denial of coverage for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of ... has been named by MedEsthetics magazine as the Best Single Physician Practice in the ... the many elite aesthetic physicians honored by the industry publication. , Dr. Vitenas ...
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
Breaking Medicine News(10 mins):